From correspondents in Haryana, India, 06:02 PM IST

India's largest drug maker Ranbaxy Laboratories posted a global operating loss of Rs.49 million ($1.01 million) in the third quarter ended Sept 30, down 103 percent from an operating profit of Rs.1.62 billion ($36 million) that the company earned in the comparable period last year, top company officials said here Friday.

The figure excludes foregn exchange losses and losses on translation and exceptional items.

The company's global sales, however, grew 14.3 percent to Rs.18.88 billion ($420 million) up from Rs.16.52 billion ($367 million) that the company posted in the comparable period of last year, the company said.

(Staff Writer, © IANS)